Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers?
about
Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsSelective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum.Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptorPotentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates.Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior.Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a.Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthoodFluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.A review of psychostimulant-induced neuroadaptation in developing animals.Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.The 5-HT1B serotonin receptor regulates methylphenidate-induced gene expression in the striatum: Differential effects on immediate-early genes.
P2860
Q22251215-A55427E6-8CB0-4AE7-AD5C-324F5A2CC056Q34065820-41681D19-E091-40F7-809F-A6A8E59C2943Q34602540-60ED66E7-7C06-4A10-9513-285850750A07Q34707811-A9BED1DF-97A9-439D-8763-FB709D4EA787Q35090725-1567D68F-C988-44E8-9F44-86B728468C42Q35096339-B99C05A2-022E-4F41-B58F-29A7D57E79DFQ35113807-5F3A7EA3-9378-4DD2-ACD1-C48E92FC4069Q36177070-9938CBFD-0C5B-4D81-B4A7-0050B656B009Q37130105-ED766AD1-8F12-45BA-8FCD-6905BEA3BE79Q37879918-A0905B02-071C-4E1E-B91F-1F3F945D67FEQ42112342-2B546DFB-414D-49AE-83DC-4F8855FBB6AAQ52313590-000CF30F-E380-4399-A540-DB3FDB348114
P2860
Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers?
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Fluoxetine potentiates methylp ...... or use of cognitive enhancers?
@ast
Fluoxetine potentiates methylp ...... or use of cognitive enhancers?
@en
type
label
Fluoxetine potentiates methylp ...... or use of cognitive enhancers?
@ast
Fluoxetine potentiates methylp ...... or use of cognitive enhancers?
@en
prefLabel
Fluoxetine potentiates methylp ...... or use of cognitive enhancers?
@ast
Fluoxetine potentiates methylp ...... or use of cognitive enhancers?
@en
P2093
P2860
P1476
Fluoxetine potentiates methylp ...... or use of cognitive enhancers?
@en
P2093
Heinz Steiner
Michela Marinelli
Vincent Van Waes
P2860
P304
P356
10.1016/J.BIOPSYCH.2009.10.004
P407
P577
2009-11-22T00:00:00Z